Guo, Jianxia and Parise, Robert A and Joseph, Erin and Lan, Jing and Pan, Su-Shu and Joo, Beomjun and Egorin, Merrill J and Wipf, Peter and Lazo, John S and Eiseman, Julie L
(2007)
Pharmacology and antitumor activity of a quinolinedione Cdc25 phosphatase inhibitor DA3003-1 (NSC 663284).
Anticancer Res, 27 (5A).
3067 - 3073.
ISSN 0250-7005
![[img]](http://d-scholarship-dev.library.pitt.edu/style/images/fileicons/text_plain.png) |
Plain Text (licence)
Available under License : See the attached license file.
Download (1kB)
|
Abstract
Cdc25 protein phosphatases are regulators of cyclin-dependent kinases and are often highly expressed in human malignancies. Few small molecule inhibitors of the Cdc25 phosphatase family have been identified and little is known about their disposition, metabolism or efficacy in xenograft models. In this study, the efficacy, pharmacokinetics, and metabolism of a potent quinolinedione Cdc25 phosphatase inhibitor, DA3003-1, in mice was examined. DA3003-1 inhibited the growth of subcutaneous human colon HT29 xenografts in SCID mice. After a single i.v. dose of 5 mg/kg, DA3003-1 was not detectable in plasma or tissues beyond 5 min. In vitro studies showed that DA3003-1 was rapidly dechlorinated and conjugated to glutathione. Following DA3003-1 treatment of tumor-bearing SCID mice, reduced glutathione concentrations in HT29 tumor were decreased to a greater extent and remained decreased for longer than the reduced glutathione concentrations in liver and kidneys. These studies suggest that the minimal antitumor activity of DA3003-1 in mice may be due to its rapid metabolism.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
Article
|
Status: |
Published |
Creators/Authors: |
Creators | Email | Pitt Username | ORCID ![](/images/orcid_id_24x24.png) |
---|
Guo, Jianxia | | | | Parise, Robert A | | | | Joseph, Erin | | | | Lan, Jing | | | | Pan, Su-Shu | | | | Joo, Beomjun | | | | Egorin, Merrill J | | | | Wipf, Peter | pwipf@pitt.edu | PWIPF | | Lazo, John S | | | | Eiseman, Julie L | | | |
|
Date: |
September 2007 |
Date Type: |
Publication |
Journal or Publication Title: |
Anticancer Res |
Volume: |
27 |
Number: |
5A |
Page Range: |
3067 - 3073 |
Schools and Programs: |
Dietrich School of Arts and Sciences > Chemistry |
Refereed: |
Yes |
Uncontrolled Keywords: |
Animals, Antineoplastic Agents, Cell Line, Tumor, Colonic Neoplasms, Enzyme Inhibitors, Female, Glutathione, Glutathione Transferase, HT29 Cells, Humans, Mice, Mice, Inbred BALB C, Mice, SCID, Quinolones, Quinones, Xenograft Model Antitumor Assays, cdc25 Phosphatases |
ISSN: |
0250-7005 |
Funders: |
NCATS NIH HHS (UL1 TR000005), NCI NIH HHS (CA78039), NCI NIH HHS (P30CA47904-14) |
MeSH Headings: |
Animals; Antineoplastic Agents--blood; Antineoplastic Agents--pharmacokinetics; Antineoplastic Agents--pharmacology; Antineoplastic Agents--toxicity; Cell Line, Tumor; Colonic Neoplasms--drug therapy; Enzyme Inhibitors--blood; Enzyme Inhibitors--pharmacokinetics; Enzyme Inhibitors--pharmacology; Enzyme Inhibitors--toxicity; Female; Glutathione--metabolism; Glutathione Transferase--metabolism; HT29 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Quinolones--blood; Quinolones--pharmacokinetics; Quinolones--pharmacology; Quinolones--toxicity; Quinones--blood; Quinones--pharmacokinetics; Quinones--pharmacology; Quinones--toxicity; Xenograft Model Antitumor Assays; cdc25 Phosphatases--antagonists & inhibitors |
PubMed ID: |
17970046 |
Date Deposited: |
07 Aug 2013 15:44 |
Last Modified: |
13 Oct 2017 23:56 |
URI: |
http://d-scholarship-dev.library.pitt.edu/id/eprint/19425 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
![View Item View Item](/style/images/action_view.png) |
View Item |